Peers Price Chg Day Year Date
AbbVie 166.20 1.60 0.97% 15.87% May/17
Bristol-Myers Squibb 44.03 -0.15 -0.34% -32.98% May/17
Gilead Sciences 67.71 -0.20 -0.29% -13.43% May/17
Incyte 57.11 0.27 0.48% -10.25% May/17
Merck 131.20 -0.07 -0.05% 15.09% May/17

Indexes Price Day Year Date
USND 16686 -12.35 -0.07% 31.50% May/17
US2000 2095 0.40 0.02% 17.35% May/17

Galectin Therapeutics traded at $3.94 this Tuesday April 9th, increasing $0.20 or 5.35 percent since the previous trading session. Looking back, over the last four weeks, Galectin Therapeutics gained 96.02 percent. Over the last 12 months, its price rose by 95.05 percent. Looking ahead, we forecast Galectin Therapeutics to be priced at 3.90 by the end of this quarter and at 3.79 in one year, according to Trading Economics global macro models projections and analysts expectations.